Sheppard Mullin Richter & Hampton LLP has brought in a former Sidley Austin LLP partner with years of experience advising life science companies on a variety of U.S. Food and Drug Administration matters, ranging from preparing for inspections to product safety.
A former Miami-area hospital director pled guilty Wednesday in Florida federal court to conspiring to defraud the United States and paying and receiving health care kickbacks as part of a $1 billion health care fraud scheme.
Walgreens Boots Alliance Inc. has inked settlements worth $269 million to end False Claims Act allegations of egregious overbilling for various drugs, the U.S. Department of Justice said Tuesday, marking some of the largest FCA payouts ever by a retail pharmacy.
A Maryland appellate court on Friday upheld the dismissal of a suit accusing the University of Maryland Medical Center of negligently treating a man’s MRSA infection that led to a total knee replacement, saying the suit was untimely filed.
The First Circuit on Tuesday affirmed a lower court’s toss of a suit that alleged a Massachusetts hospital worker was wrongly terminated for his age and gender, finding there was “extensive support” for the unbiased reason the hospital gave for his dismissal.
An Illinois federal judge said Tuesday that Enclarity Inc. was too slow to raise jurisdictional issues in its attempt to block claims by putative class members from outside the state in a case over unsolicited faxes, deciding a recent U.S. Supreme Court ruling on jurisdiction did not excuse the delay.
A Johnson & Johnson unit will pay $120 million to end a wide-ranging investigation into whether it misled customers about the longevity and efficacy of its hip replacement devices, attorneys general in New York and Texas announced Tuesday.
A California federal judge has granted a preliminary injunction barring a chain of shuttered Southern California rehabilitation centers from selling off various assets while the company faces a suit accusing it of misusing money meant to go toward a self-funded health benefit plan.
An $11.15 million settlement in an Employee Retirement Income Security Act class action over an embattled retirement plan for Rhode Island hospital workers should be approved, the receiver for the plan asserted Monday, ripping objections to the agreement from other parties to the suit.
The U.S. Food and Drug Administration's increasingly docile enforcement posture toward pharmaceutical advertisements may be emboldening drugmakers to take promotional liberties, a potentially perilous move despite the laid-back oversight. Here, experts share eight promotional pitfalls that pharma compliance officers need to know in today's enforcement environment.
The U.S. Food and Drug Administration on Tuesday released final guidance outlining an updated pathway for bringing medical devices to market that uses objective performance criteria to show that the devices are safe and effective.
Cash-strapped plaintiffs and their families suing the federal government for medical malpractice are among those adversely affected by the ongoing government shutdown, which has become yet another hurdle preventing them from having their day in court, their attorneys said.
An Ohio federal judge on Friday blocked drug distributors from trying again to keep racketeering allegations out of a bellwether trial in the opioid multidistrict litigation, rejecting assertions that enormous damages associated with racketeering will hinder settlement talks.
New York University’s teaching hospitals failed to fully compensate security guards for overtime work and skimped on pay for required duties before and after shifts, according to a putative class action filed Friday in New York state court.
The U.S. Department of Health and Human Services chided California on Friday over a court-invalidated state law that had required pregnancy resource centers to post information about abortion services, saying it flouted federal statutes barring discrimination against anti-abortion providers.
Health insurance giant United HealthCare Services Inc. has slapped a host of generic-drug makers with a sprawling lawsuit in Minnesota federal court alleging they conspired to hike prices on a range of medications and saying “collusion in the generic pharmaceutical industry is well established at this point.”
Providers of a West Coast health and welfare plan urged a California federal court on Thursday to dismiss a group of dockworkers' suit over $4.1 million in unpaid health-care claims, arguing that the group's allegations aren't backed up by facts and that some of the workers had already fought out the issue in arbitration.
Lennar has reportedly paid $17 million for a Miami development site, Baptist Health South Florida is said to have bought a former Toys R Us store for $15.8 million, and Bridge Development Partners has reportedly dropped $68 million on a Los Angeles warehouse complex.
The Fifth Circuit has vacated an injunction barring Texas from excluding Planned Parenthood affiliates from Medicaid based on graphic videos released by an anti-abortion group, saying the district court judge used the wrong standard and ignored the administrative record.
A New Jersey appeals court declined Thursday to revive medical malpractice claims against a Rowan University-employed surgeon, saying the couple suing failed to provide proper notice of who was in their crosshairs.
Earlier this month, a California federal court denied discovery into the identification of third-party funders with a financial interest in the outcome of an underlying patent infringement action. This decision in MLC v. Micron follows a long line of well-reasoned precedent across U.S. federal courts, say Matthew Harrison and Sarah Jacobson of Bentham IMF.
Team-based specialization in mass tort litigation defense allows each member to draw on individual strengths, maximizing their contribution. A core tenet of this approach is using settlement counsel to focus on strategic initiatives and end-game resolution efforts, separate from the heated battle lines of the litigation, say attorneys at Faegre Baker Daniels.
U.S. Supreme Court oral arguments in Azar v. Allina Health Services seemed to favor a ruling that could mean billions of dollars in additional Medicare payments to many hospitals. But the case also could significantly affect Centers for Medicare & Medicaid Services operations, say Mark Polston and Matthew Horton of King & Spalding LLP.
The lack of minority partners comes at a high cost to firms, say attorneys at Lightfoot Franklin & White LLC, as they suggest several practical ways to tackle this problem.
The New Jersey Department of Banking and Insurance has released a bulletin clarifying its law designed to protect consumers from "hidden" out-of-network health providers, but many questions still remain, say Cynthia Borrelli and Michael Morris of Bressler Amery & Ross PC.
For those navigating the California class action landscape in 2019, it pays to know what happened in 2018. William Stern of Covington & Burling LLP looks back at the most important developments and discusses what to expect going forward.
The Office of Inspector General at the U.S. Department of Health and Human Services entered into only 37 new corporate integrity agreements last year — the lowest number since 2012 — but it was an important year on the policy front, say attorneys with Skadden Arps Slate Meagher & Flom LLP.
Alternative dispute resolution providers have made great strides toward diversity, but recent statistics show there is still work to be done. There are certain steps ADR providers can take to actively recruit more women and minority candidates to serve as arbitrators and mediators, says James Jenkins of the American Arbitration Association.
Alternative fee agreements can help align law firm and client interests, increase efficiency and eliminate corporate extortion, among other benefits. They are the best thing to happen to the practice of law in decades, says Kelly Eisenlohr-Moul at Dinsmore & Shohl LLP.
In New Haven v. Purdue, a Connecticut state judge ruled last week that opioid manufacturers are not liable for cities' emergency and social services costs. This decision protects liability insurance from being transformed into a funding mechanism for social problems that it was not designed to cover, say Patrick Bedell and Kevin Harris of BatesCarey LLP.